Limited Submission Funding Opportunity: NIH Director’s Early Independence Awards

URL: https://grants.nih.gov/grants/guide/rfa-files/RFA-RM-21-018.html

OBJECTIVES:

The NIH Director’s Early Independence Award supports exceptional junior investigators who wish to pursue independent research soon after completion of their terminal doctoral degree or post-graduate clinical training, thereby forgoing the traditional post-doctoral training period and accelerating their entry into an independent research career. For the program to support the best possible researchers and research, applications are sought which reflect the full diversity of the research workforce. Individuals from diverse backgrounds, including those from underrepresented groups and from the full spectrum of eligible institutions in all geographic locations, are strongly encouraged to apply to this Funding Opportunity Announcement. In addition, applications in all topics relevant to the broad mission of NIH are welcome, including, but not limited to, topics in the behavioral, social, biomedical, applied, and formal sciences and topics that may involve basic, translational, or clinical research.

FUNDING INFORMATION: 

Awards will be for up to $250,000 in direct costs per year for up to 5 years

ELIGIBILITY RESTRICTIONS:

Individuals are eligible only if they, at the time of application submission, do not have research independence. Lack of research independence is defined functionally rather than by position title. Eligible individuals must have all the following characteristics:

  • The PD/PI’s current research agenda is set through concurrence with mentors.
  • The PD/PI’s research is funded primarily through support to other investigators (mentored fellowships such as NIH F31 or F32 Fellowships or NSF Graduate Research Fellowships do not preclude eligibility).
  • The PD/PI does not have any space assigned directly by the institution for the conduct of his/her research.
  • The PD/PI, according to institutional policy, cannot apply for an NIH R01 grant without special waiver or exemption from the institution.

Given the focus on early research independence, the receipt date of the terminal doctoral degree or end of post-graduate clinical training of the PD/PI must be between June 1, 2020 and September 30, 2022. The degree receipt date is that which appears on the official transcript for the degree. The end of post-graduate clinical training includes residency and fellowship periods. The PD/PI must not have served as a post-doctoral fellow for more than twelve months before June 1, 2020.

At the time of award, either 1) the Early Independence investigator must have received a PhD, MD, DO, DC, DDS, DVM, OD, DPM, ScD, EngD, DrPH, DNSc, ND (Doctor of Naturopathy), PharmD, DSW, PsyD, or equivalent doctoral degree from an accredited domestic or foreign institution (it is the responsibility of the sponsoring institution to determine if a foreign doctoral degree is equivalent), or 2) an authorized official of the degree-granting or training institution must certify that all degree requirements have been met and that the receipt date of the degree (as will appear on the transcript) will be before September 30, 2022.  An authorized official of the host institution must certify that the PD/PI will be able to conduct independent research at the institution at the time of the project start date.

INTERNAL SELECTION PROCESS:

Interested investigators should submit the following materials via InfoReady Review by DATE: 7/9/2021

  • Questions outlined in InfoReady Review application;
  • A letter of recommendation from the appropriate department chair or dean
  • A brief statement (up to 2 pages) by the candidate describing their scientific achievements and proposed project;
  • A brief budget outline for the proposed research
  • Up-to-date CV or biosketch.

A faculty committee will review internal proposals and select nominees.

DEADLINES:
Internal Materials Due: Friday, July 9, 2021

Sponsor Deadline:

  • LOI: Tuesday, August 3, 2021
  • Application: Friday, September 3, 2021

Information For...